ArticleThe Journal of the Egyptian Public Health Association2024
Matters arising: On the cost-effectiveness for the Italian National Health Service of nab-paclitaxel plus gemcitabine vs gemcitabine alone in metastatic pancreatic cancer.
Carlo LazzaroPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.